Orbital Lymphatic Malformations Are Associated With Intracranial Vascular Anomalies
Open Access
- 19 August 2026
- journal article
- research article
- Published by Wiley in The Laryngoscope
Abstract
Objectives: Orbital lymphatic malformations (OLMs) are a rare type of lymphatic malformation involving the soft tissues within the bony orbit. OLMs present specific treatment challenges and cause significant morbidity. The contribution of pathologic genetic variants and potential association of intracranial vascular anomalies with OLMs has yet to be described. We hypothesized that (1) OLMs are indicators of underlying cerebrofacial venous metameric syndrome (CVMS) and are associated with intracranial vascular anomalies, and (2) OLMs are caused by PIK3CA variants and are candidates for targeted medical therapy. Methods: Retrospective case review was performed for patients with OLMs treated at a single institution from 2000 to 2025. Diagnosis of CVMS was made via magnetic resonance imaging (MRI) based on established criteria of segmental distribution of ocular, facial, and cerebral vascular malformations. Symptoms, MRI and genetic findings, and management are described. Results: Seven of 412 patients with head and neck lymphatic malformations had OLM. Common symptoms included eye swelling ( n = 7), ptosis ( n = 3), and headache ( n = 5). All patients were diagnosed with CVMS on MRI. All patients underwent surgical resection and were candidates for targeted medical therapy after tissue‐based DNA sequencing revealed “hotspot” PIK3CA variants p.E542K ( n = 4) and p.H1047R ( n = 3). Five patients were started on alpelisib, resulting in symptom improvement at 6 months of treatment. Conclusion: OLMs were associated with intracranial vascular anomalies, meeting radiographic criteria for CVMS. All patients had “hotspot” PIK3CA variants on tissue‐based genetic testing. Screening for intracranial vascular anomalies and targeted medical therapy with PI3K/AKT/mTOR pathway inhibitors should be considered in OLM management. Level of Evidence: 3.Keywords
Funding Information
- American Society of Pediatric Otolaryngology (1060516)
This publication has 22 references indexed in Scilit:
- Alpelisib for the treatment of PIK3CA-related head and neck lymphatic malformations and overgrowthGenetics in Medicine, 2022
- Somatic activating BRAF variants cause isolated lymphatic malformationsHuman Genetics and Genomics Advances, 2022
- Pediatric Cerebral Cavernous MalformationsPediatric Neurology, 2021
- Use of percutaneous bleomycin sclerotherapy for orbital lymphatic malformationsOrbit, 2018
- Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin PathwayThe Journal of Molecular Diagnostics, 2017
- Orbital lymphaticovenous malformations: Current and future treatmentsSurvey of Ophthalmology, 2015
- Lymphatic and Other Vascular Malformative/Overgrowth Disorders Are Caused by Somatic Mutations in PIK3CAThe Journal of Pediatrics, 2015
- Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES SyndromeThe American Journal of Human Genetics, 2012
- Segmental Neurovascular Syndromes in ChildrenNeuroimaging Clinics Of North America, 2007
- Periorbital Lymphatic Malformation: Clinical Course and Management in 42 PatientsPlastic and Reconstructive Surgery, 2005